rewirebio.iobenchmarks
Configuration

Ladon + clinical covariates, summed standardised risk scores (held-out trials)

Equal-weight sum of the Ladon survival risk score and a BMRetriever-7B clinical-covariate risk score, each standardised within the evaluated trial and endpoint.

3 evaluations · 3 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for Ladon + clinical covariates, summed standardised risk scores (held-out trials). Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluated Checkpoint: Embeddings from the survival-supervised Ladon model

Evaluations and results

3 evaluations · 3 results. Different protocols are not a single leaderboard.

Sorted by Concordance index (Uno's C-index, overall survival, OAK (699 patients), predictor fitted on other cohorts) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetConcordance index (Uno's C-index, overall survival, OAK (699 patients), predictor fitted on other cohorts)Hazard ratio (hazard ratio, higher-risk half against lower-risk half at the median predicted risk, overall survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over six trials)Hazard ratio (hazard ratio, higher-risk half against lower-risk half at the median predicted risk, progression-free survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over three trials)
Ladon + clinical covariates, summed standardised risk scores (held-out trials)EvaluationOAK overall survival, Uno C-index of a predictor fitted on other cohorts, OAK RNA-profiled patients (699)0.61Not reportedNot reported
Ladon + clinical covariates, summed standardised risk scores (held-out trials)EvaluationHeld-out trials, OS hazard ratio of higher- against lower-risk half, geometric mean over six trials, Six held-out trials with overall survivalNot reported2.15Not reported
Ladon + clinical covariates, summed standardised risk scores (held-out trials)EvaluationHeld-out trials, PFS hazard ratio of higher- against lower-risk half, geometric mean over three trials, Three held-out trials with progression-free survivalNot reportedNot reported2
All 3 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Ladon + clinical covariates, summed standardised risk scores (held-out trials)Protocol: Held-out trials, OS hazard ratio of higher- against lower-risk half, geometric mean over six trials
Dataset subset: Six held-out trials with overall survival
2.15 Hazard ratio (hazard ratio, higher-risk half against lower-risk half at the median predicted risk, overall survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over six trials)
unitless · higher

Uncertainty: Not reported by the source: Per-trial dots and a bar only; no interval is printed.

Coverage: 6/6 trials scored (IMbrave150 uses Ladon alone in the combined predictor.)

Author-reported evaluation · Source checked
Methods, coverage and source

Ladon + clinical covariates, held-out trials OS hazard ratio

ladon-20261115-protocol-trials-os-hazard-ratio

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 3 (page 7), row 'Ladon + clinical covariates', label 'OS 2.15'
Configuration: Ladon + clinical covariates, summed standardised risk scores (held-out trials)Protocol: Held-out trials, PFS hazard ratio of higher- against lower-risk half, geometric mean over three trials
Dataset subset: Three held-out trials with progression-free survival
2 Hazard ratio (hazard ratio, higher-risk half against lower-risk half at the median predicted risk, progression-free survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over three trials)
unitless · higher

Uncertainty: Not reported by the source: Per-trial dots and a bar only; no interval is printed.

Coverage: 3/3 trials scored (IMbrave150 uses Ladon alone in the combined predictor.)

Author-reported evaluation · Source checked
Methods, coverage and source

Ladon + clinical covariates, held-out trials PFS hazard ratio

ladon-20261115-protocol-trials-pfs-hazard-ratio

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 3 (page 7), row 'Ladon + clinical covariates', label 'PFS 2.00'
Configuration: Ladon + clinical covariates, summed standardised risk scores (held-out trials)Protocol: OAK overall survival, Uno C-index of a predictor fitted on other cohorts
Dataset subset: OAK RNA-profiled patients (699)
0.61 Concordance index (Uno's C-index, overall survival, OAK (699 patients), predictor fitted on other cohorts)
unitless · higher

Uncertainty: Not reported by the source: No interval is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Ladon + clinical covariates, OAK overall survival, Uno C-index

ladon-20261115-protocol-oak-os-uno

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 4 caption (page 8), '(Uno’s C-index in OAK, 0.61)'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ladon-20261115-config-ladon-clinical-trial-survival.

Source locator: Page 13, Methods 'Survival in held-out trials', paragraph beginning 'We fit a separate Cox predictor on the clinical-covariate embeddings'; page 14, first line

Related records

How to cite

Ladon + clinical covariates, summed standardised risk scores (held-out trials). Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/ladon-20261115-config-ladon-clinical-trial-survival/

Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction